ContractINVO Bioscience, Inc. • June 26th, 2020 • Surgical & medical instruments & apparatus • Nevada
THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED OR SOLD IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, REGISTRATION UNDER SAID ACT.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 26th, 2020 • INVO Bioscience, Inc. • Surgical & medical instruments & apparatus • Nevada
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of June __, 2020, by and among INVO Bioscience, Inc., a Nevada corporation (the “Company”), and the subscribers identified on the signature page hereto (each a “Subscriber” and collectively “Subscribers”).
CONFIDENTIAL March 6, 2020 Mr. Steve Shum Chief Executive Officer INVO Bioscience, Inc. Sarasota, FL 43240Letter Agreement • June 26th, 2020 • INVO Bioscience, Inc. • Surgical & medical instruments & apparatus • New York
This letter agreement (the “Agreement”) confirms the terms and conditions that will govern INVO Bioscience, Inc. (together with its subsidiaries, predecessors, and successors, the “Company”) engagement of Tribal Capital Markets, LLC (together with its affiliates, “Tribal”) as the Company’s exclusive placement agent in connection with an offering or series of offerings of Company securities (the “Engagement”).
UNIT PURCHASE OPTIONINVO Bioscience, Inc. • June 26th, 2020 • Surgical & medical instruments & apparatus • Nevada
THIS UNIT PURCHASE OPTION (the “Purchase Option”) certifies that, for value received, ___________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June __, 2020 (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from INVO Bioscience, Inc., a Nevada corporation (the “Company”), up to _______________ units (as subject to adjustment hereunder, the “Units”), each Unit consisting of (A) one share of Common Stock (“Unit Shares”) and (B) a warrant (each, a “Warrant”) to purchase one share of Common Stock (“Warrant Shares”) having an expiration date five years after the date of issuance. Each Warrant will have the same terms as this Purchase Option except that it will have an exercise price of $6.00 per share and each W
